GFAP and Alzheimer disease: We found that elevated pulse pressure was the most sensitive metric, negativelyassociated with axonal degeneration, astrocytic activation, and AD pathobiology (NfL, GFAP,pTau181), while elevated systolic blood pressure associated with increasing pTau burden(pTau181).